AKQA
29.8.2017 08:02:08 CEST | Business Wire | Press release
DIS/PLAY is a digital agency that provides innovation, strategy, user experience, design, and technical development solutions to clients. Employing more than 100 people in Copenhagen and Aarhus, DIS/PLAY’s clients include ECCO, Amnesty International and Vestas.
This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20170828005997/en/
DIS/PLAY’s Copenhagen and Aarhus studios will become part of AKQA, further building AKQA’s European presence and capabilities while providing DIS/PLAY with access to AKQA’s global network and resources.
Steffen Blauenfeldt Otkjær, DIS/PLAY’s CEO said: “AKQA leads globally in creativity and innovation, and DIS/PLAY’S strong technical capabilities make this relationship a natural fit. We are incredibly excited about the opportunities this partnership will create for our clients and team.”
Ajaz Ahmed, AKQA’s CEO said: “It has been a long held aspiration for AKQA to have a studio in Denmark, and thanks to our partnership with DIS/PLAY, that aspiration has become a reality. In the conversations that led to this partnership it quickly became apparent that DIS/PLAY’s ethos mirrors the values of AKQA.”
He added: “Denmark is one of the world’s most influential, beloved and respected nations, consistently taking the top spot on the United Nations World Happiness Report and first place in the Social Progress Index report. We look forward to learning from, and amplifying, this enlightened philosophy.”
Over the past two years, AKQA has added studios in many of the world’s cultural capitals including Sydney, Melbourne, Singapore, São Paulo, Milan, Venice and London. Combined with DIS/PLAY’s additional 110 employees, AKQA now has over 2,100 employees in 23 studios across the USA, Europe, Asia, and Australasia.
About AKQA
A recognised pioneer, AKQA is the global brand experience studio inspired by the imaginative application of art and science. AKQA has grown to become one of the world's most awarded digital agencies. AKQA is part of WPP, the world's largest communications services group. www.akqa.com
About DIS/PLAY
DIS/PLAY is one of the leading digital agencies in Denmark. Specialised in digital strategy, creativity and technology, DIS/PLAY employs 110 people in Copenhagen and Aarhus, who provide both Danish and global companies with quality work on a wide range of platforms - across all digital touchpoints. www.dis-play.dk
View source version on businesswire.com: http://www.businesswire.com/news/home/20170828005997/en/
Contact:
AKQA
Gyve Safavi, +44 79 0070 3311
gyve.safavi@akqa.com
or
DIS/PLAY
Jacob
Danstrup, +45 26 85 99 87
jda@dis-play.dk
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Owkin Creates New Spin out Waiv, Formerly Owkin Dx, With $33M Financing12.3.2026 14:30:00 CET | Press release
Investment lead by OTB Ventures and Alpha Intelligence CapitalWaiv develops AI-powered precision testing to better identify and stratify patients in the clinic and in clinical trials, transforming patient careWaiv extends Owkin’s strategy of real-world validation for its AI Owkin, the AI company on a mission to solve the complexity of biology, today announced the spin out of Waiv, formerly known as Owkin Dx. The move follows significant investor interest and positions Waiv to bring AI-powered precision testing for better identification of patients in the clinic and in clinical trials, to transform patient care. This follows on from the successful launch of Bioptimus, an Owkin incubated company, in February 2024. Waiv translates AI innovation into real-world clinical impact, developing tests that predict biomarkers and patient outcomes, including RlapsRisk BC for prognostic risk profiling. With multiple tests already in use in clinical settings, its deployment platform Destra, and colla
RQM+ Launches SMART Solutions Life Cycle Partnership Model12.3.2026 14:30:00 CET | Press release
Helps MedTech Companies Navigate MDR, IVDR, and AI-Enabled Device Development RQM+, a leading MedTech CRO offering regulatory consulting, clinical trial, laboratory, and reimbursement services, today announced the launch of SMART Solutions, a life cycle partnership model designed to help medical device and diagnostics companies manage growing regulatory and development complexity. SMART Solutions introduces a strategy-led operating framework that unifies regulatory, quality, clinical, reimbursement, and laboratory expertise to support MedTech companies across the entire product life cycle to help reduce risk from early development through post-market. “MedTech companies are navigating unprecedented complexity as regulatory expectations evolve, product innovation accelerates, and post-market expectations are expanding,” said John Potthoff, Ph.D., chief executive officer of RQM+. “SMART Solutions moves beyond traditional consulting by providing an integrated life cycle partnership that h
Cryptio Raises $45m Series B as Digital Assets Move Into Regulated Financial Markets12.3.2026 14:06:00 CET | Press release
The system of record for tokenized finance – ERP infrastructure for institutions operating in digital assets Cryptio, a leader in financial data transformation and enterprise resource planning (ERP) applications for regulated digital assets, announced today a $45 million Series B funding round co-led by BlackFin Capital Partners and Sentinel Global, with participation from 1kx, Alven, BlueYard Capital and Ledger Cathay Capital. Banks, exchanges, asset managers, including Société Générale’s SG Forge, Circle, Gemini, and Securitize rely on Cryptio to ensure financial integrity across their digital assets businesses. Existing ERP systems fall short for digital assets Traditional ERP and accounting systems were not designed for blockchain-native assets, real-time reporting, or modern custody frameworks. As regulated financial institutions expand into stablecoins, tokenized securities and other on-chain instruments, these limitations create material operational and reporting challenges. Cry
HyperLight Introduces 145 GHz Reference Modulators to Enable 448Gbps per Lane Datacom and 260GBaud Telecom Development12.3.2026 14:03:00 CET | Press release
HyperLight Corporation, creator of the TFLN Chiplet™ platform, today announced the release of its 145 GHz Packaged Intensity Modulator (IM), expanding the company‘s high-speed modulator portfolio. The new device is designed for ultra-wide modulation bandwidth, high signal fidelity, and stable operation control, enabling 448 Gbps per lane intensity-modulated-direct-detection (IMDD), 260 GBaud coherent links, and broadband RF photonics systems. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312319685/en/ Fig. 1: HyperLight’s 145 GHz intensity modulator for 448Gbps per lane IMDD and 260GBaud coherent applications, with operational electro-optical bandwidth >145GHz, stable bias control, 0.8 mm-connector; available in O-, C-, and L-bands. As symbol rates and analog bandwidth requirements continue to rise across data center interconnects, AI-driven photonics infrastructure, and laboratory test environments, system architects in
Enodia Therapeutics Strengthens Sec61 Portfolio Through Acquisition of Preclinical Assets from Kezar Life Sciences12.3.2026 14:00:00 CET | Press release
Transaction deepens insights into Sec61 selectivity for targeted protein degradation, supporting accelerated development of Enodia’s novel small-molecule inhibitors Enodia Therapeutics, a biotechnology company developing novel small-molecule therapies for targeted protein degradation at the point of synthesis, and Kezar Life Sciences, Inc. (Nasdaq: KZR), a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated diseases, today announced that Enodia has acquired Kezar’s assets from its Sec61-based discovery and development program. The acquisition enables Enodia to advance its understanding of Sec61 selectivity mechanisms, expanding biological and translational insights for faster progression toward key clinical milestones. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260312627573/en/ Under the terms of the purchase agreement between Enodia and Kezar, Kezar w
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom